Tenax Therapeutics (NASDAQ: TENX) net income
Tenax Therapeutics reported a net loss of $52.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $17.6m. Earnings per share were −$1.34.
Tenax Therapeutics's best year of the last 10 was fiscal 2022. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$52.6m | — | — | −$1.34 |
| 2024 | −$17.6m | — | — | −$1.15 |
| 2023 | −$7.7m | −169.8% | — | −$31.04 |
| 2022 | $11.0m | — | — | — |
| 2021 | −$32.5m | — | — | — |
| 2020 | −$9.9m | — | — | — |
| 2019 | −$8.4m | — | — | — |
| 2018 | −$14.1m | — | — | — |
| 2017 | −$8.8m | — | — | — |
| 2016 | −$43.9m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Tenax Therapeutics net income compared with its sector
By net income for its latest fiscal year, Tenax Therapeutics ranks 261st of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 259th | Evolus | −$51.6m | −17.4% |
| 260th | Invivyd | −$52.5m | −98.2% |
| 261st | Tenax Therapeutics | −$52.6m | — |
| 262nd | Orchestra BioMed | −$52.7m | −157.4% |
| 263rd | CVRX | −$53.3m | −94.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Tenax Therapeutics
- How much did Tenax Therapeutics earn in fiscal 2025?
- Tenax Therapeutics reported a net loss of $52.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $17.6m.
- What are the earnings per share of Tenax Therapeutics?
- They were −$1.34 in fiscal 2025, compared with −$1.15 in fiscal 2024.
- What was the most profitable year for Tenax Therapeutics?
- Of its last 10 fiscal years, fiscal 2022, with $11.0m.
- Where does Tenax Therapeutics rank in its sector by net income?
- It ranks 261st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Tenax Therapeutics come from?
- From the annual report (Form 10-K) that Tenax Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Tenax Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Tenax Therapeutics: the Tenax Therapeutics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.